The customer did not provide patient demographics such as age, date of birth, sex or weight.Service was not dispatched for this event.There is no indication that the access hybritech psa reagent was returned for evaluation.In conclusion, an assignable cause of the non-reproducibly false low access hybritech psa result is unknown and cannot be determined with the available information.
|
On (b)(6) 2015, the customer reported one (1) non-reproducibly false low prostate-specific antigen (access hybritech psa) result which was obtained on the laboratory's unicel dxi 600 access immunoassay system (serial number (b)(4)) for one (1) patient.The initial access hybritech psa result of 82.069 ng/ml was reported outside of the laboratory.The lab technician questioned the result and the same sample was repeated eight (8) times on the same unicel dxi 600 access immunoassay system.The repeated results recovered reproducibly high with results of 128.2 ng/ml, 132.691 ng/ml, 143.183 ng/ml, 142.8 ng/ml, 137.595 ng/ml, 139.784 ng/ml, 142.48 ng/ml and 135.734 ng/ml obtained.There were no reports of patient injury or change to patient treatment associated with this event.Calibration prior to this event was passing assay specifications.One level of quality control (qc) was running out of the customer's established range on the date of event.A system check performed after this event was passing within instrument specifications.There were no errors posted in the event log.Two (2) precision studies were performed using level 3 qc.The precision studies met assay and system specifications.The sample was collected in a becton dickinson (bd) serum gold top tube on (b)(6) 2015 and was centrifuged at 3000 revolutions per minute (rpm) for 10 minutes at room temperature.The sample was stored refrigerated until it was tested on (b)(6) 2015.The customer noted no sample integrity issues.
|